Ronald Salem, MD, FACS, FRSC (Ed), FRCS(C), MBChB
Lampman Professor of Surgery (Oncology)Cards
Contact Info
About
Titles
Lampman Professor of Surgery (Oncology)
Biography
Ronald R. Salem, MD earned his medical degree from University of Rhodesia and is a Board Certified Surgeon. Passionate about improving the lives of patients with cancer, he is committed to advancing medical and surgical treatment and integrating the latest techniques and minimally invasive surgery in his clinical practice. He is one of the few surgeons in Connecticut with a high volume practice performing the Whipple procedure.
Dr. Salem specializes in malignant and pre-malignant diseases of the pancreas, liver and biliary system, the gall bladder, stomach, colon and rectum, lymphoma, neuroendocrine tumors of the pancreas and gastrointestinal tract, as well as liver tumors in pregnant women.
His clinical research includes a special focus on optimizing clinical outcomes in patients undergoing pancreatic surgery, combined modality therapy for esophageal cancer and the management of pancreatic cysts and benign and malignant liver tumors.
He has received many honors and recognitions, including The Best Doctors, N.Y. Metro Area annually for over ten years; Best Doctors in Connecticut and Top Minimally Invasive Surgeons, NY Metro Area.
He was recently awarded the prestigious David and Cindy Lefell Award for clinical excellence, the Yale New Haven Hospital Heroes Award, the Smilow Cancer Center Clinical Award the Alvin Feinstein Teaching Award and has received the Chief Resident in Surgery Teaching Award on seven separate occasions.
Appointments
Surgical Oncology
Section ChiefDualSurgical Oncology
Professor Phased RetirementPrimary
Other Departments & Organizations
- Center for Gastrointestinal Cancers
- Hepatic Arterial Infusion (HAI) Program
- Hyperthermic intraperitoneal chemotherapy (HIPEC) Program
- Liver Cancer Program
- Oligometastatic Cancer Program
- Pancreatic Diseases Program
- Sarcoma Program
- Surgery
- Surgical Oncology
- Yale Cancer Center
- Yale Ventures
Education & Training
- Senior Resident
- New England Deaconess Hospital, Boston, MA (1988)
- Research Felllow
- Dana Farber Cancer Center & New England Deaconess Hospital, Boston, MA (1987)
- Resident
- Royal Postgraduate Medical School, Hammersmith Hospital, London, UK (1985)
- MD
- University of Rhodesia (1978)
- MBChB
- University of Rhodesia (1978)
- Intern
- Harare Hospital, Harare, Zimbabwe
- PGY-2 OB/GYN
- Harare Hospital, Harare, Zimbabwe
- Emergency Room Physician
- Guys Hospital, London, UK
- Chief Resident
- New England Deaconess Hospital, Boston, MA
Research
Overview
Medical Research Interests
Research at a Glance
Yale Co-Authors
Anup Sharma, PhD
John Kunstman, MD, MHS, FACS
Leah Ferrucci, PhD, MPH
Lee Ying, MD, PhD, MS, MPhil
Nita Ahuja, MD, MBA, FACS
Sajid A Khan, MD, FACS, FSSO
Publications
2024
Prolonged length of stay and omission of adjuvant therapy are associated with early mortality after pancreatic adenocarcinoma resection
Ying L, Ilagan-Ying Y, Kunstman J, Peters N, Almeida M, Blackburn H, Ferrucci L, Billingsley K, Khan S, Chhoda A, John N, Salem R, Sharma A, Ahuja N. Prolonged length of stay and omission of adjuvant therapy are associated with early mortality after pancreatic adenocarcinoma resection. Surgical Oncology Insight 2024, 1: 100007. DOI: 10.1016/j.soi.2024.100007.Peer-Reviewed Original ResearchConceptsFactors associated with early mortalityCases of pancreatic adenocarcinomaPancreatic adenocarcinoma resectionRisk of early mortalityLength of stayEarly mortalityAdjuvant chemotherapyPancreatic adenocarcinomaChemotherapy utilizationAdenocarcinoma resectionRisk factors associated with early mortalityOmission of adjuvant therapyNon-metastatic pancreatic adenocarcinomaMultivariate Cox regression modelAssociated with early mortalityPost-resection survivalIncreased risk of early mortalityParticipant Use FileProlonged hospital stayProlonged length of stayAdjuvant chemotherapy utilizationDecrease perioperative complicationsCox regression modelsNon-academic centersHospital risk factors
Clinical Trials
Current Trials
The Cancer of the Pancreas Screening-5 (CAPS5) Study
HIC ID1408014448RoleSub InvestigatorPrimary Completion Date10/31/2024Recruiting ParticipantsGenderBothAge18+ years
Academic Achievements & Community Involvement
honor Connecticut Magazine Top Docs 2016
Regional AwardConnecticut MagazineDetails04/01/2016United Stateshonor Connecticut Magazine Top Docs 2015
Regional AwardConnecticut MagazineDetails04/03/2015United Stateshonor The Best Doctors - N.Y. Metro Area
UnknownCastle, Connolly MedicalDetails01/01/2008, 01/01/2003United Stateshonor Master of Arts, Honoris Causa
UnknownYale University, New Haven, CTDetails01/01/2006United Stateshonor General Surgery Resident Teaching Award
UnknownDetails01/01/2006United States
News & Links
News
- December 12, 2024
Dr. Raul Guzman Receives the 2024 Dr. Walter E. Longo MD Award
- June 20, 2024
Chemotherapy Before Surgery Benefits Some Patients With Pancreatic Cancer
- October 27, 2023
Dr. Ronald Salem's Last Case
- October 25, 2023
Dr. Benjamin L. Judson Receives Walter E. Longo MD Award